| Effectiveness and safety of drug-eluting stents in Ontario JV Tu, J Bowen, M Chiu, DT Ko, PC Austin, Y He, R Hopkins, JE Tarride, ... New England Journal of Medicine 357 (14), 1393-1402, 2007 | 479 | 2007 |
| A review of the cost of cardiovascular disease JE Tarride, M Lim, M DesMeules, W Luo, N Burke, D O’Reilly, J Bowen, ... Canadian Journal of Cardiology 25 (6), e195-e202, 2009 | 329 | 2009 |
| The economic burden of schizophrenia in Canada in 2004 R Goeree, F Farahati, N Burke, G Blackhouse, D O’Reilly, J Pyne, ... Current medical research and opinion 21 (12), 2017-2028, 2005 | 297 | 2005 |
| The burden of illness of osteoporosis in Canada JE Tarride, RB Hopkins, WD Leslie, S Morin, JD Adachi, A Papaioannou, ... Osteoporosis International 23, 2591-2600, 2012 | 196 | 2012 |
| Analysis of health utility data when some subjects attain the upper bound of 1: are Tobit and CLAD models appropriate? EM Pullenayegum, JE Tarride, F Xie, R Goeree, HC Gerstein, D O'Reilly Value in Health 13 (4), 487-494, 2010 | 163 | 2010 |
| Systematic review and meta-analysis of transurethral resection of the prostate versus minimally invasive procedures for the treatment of benign prostatic obstruction N Burke, JP Whelan, L Goeree, RB Hopkins, K Campbell, R Goeree, ... Urology 75 (5), 1015-1022, 2010 | 145 | 2010 |
| The current economic burden of illness of osteoporosis in Canada RB Hopkins, N Burke, C Von Keyserlingk, WD Leslie, SN Morin, ... Osteoporosis International 27, 3023-3032, 2016 | 144 | 2016 |
| Validation of Chinese Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) in patients scheduled for total knee replacement F Xie, SC Li, R Goeree, JE Tarride, D O’Reilly, NN Lo, SJ Yeo, KY Yang, ... Quality of Life Research 17, 595-601, 2008 | 136 | 2008 |
| Transferability of economic evaluations: approaches and factors to consider when using results from one geographic area for another R Goeree, N Burke, D O'Reilly, A Manca, G Blackhouse, JE Tarride Current medical research and opinion 23 (4), 671-682, 2007 | 130 | 2007 |
| Transferability of health technology assessments and economic evaluations: a systematic review of approaches for assessment and application R Goeree, J He, D O’Reilly, JE Tarride, F Xie, M Lim, N Burke ClinicoEconomics and Outcomes Research, 89-104, 2011 | 128 | 2011 |
| Cost-effectiveness of pregabalin for the management of neuropathic pain associated with diabetic peripheral neuropathy and postherpetic neuralgia: a Canadian perspective JE Tarride, A Gordon, M Vera-Llonch, E Dukes, C Rousseau Clinical therapeutics 28 (11), 1922-1934, 2006 | 116 | 2006 |
| Bariatric surgery and cardiovascular outcomes in patients with obesity and cardiovascular disease: a population-based retrospective cohort study AG Doumouras, JA Wong, JM Paterson, Y Lee, B Sivapathasundaram, ... Circulation 143 (15), 1468-1480, 2021 | 113 | 2021 |
| GRADE Guidelines 30: the GRADE approach to assessing the certainty of modeled evidence—An overview in the context of health decision-making JL Brozek, C Canelo-Aybar, EA Akl, JM Bowen, J Bucher, WA Chiu, ... Journal of clinical epidemiology 129, 138-150, 2021 | 95 | 2021 |
| A review of health utilities across conditions common in paediatric and adult populations JE Tarride, N Burke, M Bischof, RB Hopkins, L Goeree, K Campbell, F Xie, ... Health and quality of life outcomes 8, 1-11, 2010 | 91 | 2010 |
| Estimation of the lifetime risk of hip fracture for women and men in Canada RB Hopkins, E Pullenayegum, R Goeree, JD Adachi, A Papaioannou, ... Osteoporosis international 23, 921-927, 2012 | 89 | 2012 |
| A multinational pharmacoeconomic evaluation of acute major depressive disorder (MDD): a comparison of cost-effectiveness between venlafaxine, SSRIs and TCAs JJ Doyle, J Casciano, S Arikian, JE Tarride, MA Gonzalez, R Casciano Value in Health 4 (1), 16-31, 2001 | 86 | 2001 |
| Methodological guidance documents for evaluation of ethical considerations in health technology assessment: a systematic review N Assasi, L Schwartz, JE Tarride, K Campbell, R Goeree Expert review of pharmacoeconomics & outcomes research 14 (2), 203-220, 2014 | 83 | 2014 |
| Estimation of the impact of diabetes-related complications on health utilities for patients with type 2 diabetes in Ontario, Canada DJ O’Reilly, F Xie, E Pullenayegum, HC Gerstein, J Greb, GK Blackhouse, ... Quality of Life Research 20, 939-943, 2011 | 77 | 2011 |
| Loss of health related quality of life following low-trauma fractures in the elderly JE Tarride, N Burke, WD Leslie, SN Morin, JD Adachi, A Papaioannou, ... BMC geriatrics 16, 1-11, 2016 | 75 | 2016 |
| The cost-effectiveness of palivizumab for respiratory syncytial virus prophylaxis in premature infants with a gestational age of 32–35 weeks: a Canadian-based analysis KL Lanctôt, ST Masoud, BA Paes, JE Tarride, A Chiu, C Hui, PL Francis, ... Current medical research and opinion 24 (11), 3223-3237, 2008 | 75 | 2008 |
